Utilities Registry – Page 4 – Center for Health Decision Science

Filter results using search terms, or by selecting one or more valuation, condition, or population.

Valuation

Population

Condition

Viewing 31 - 40 of 44 results

Title	Year(s) of data collection	Valuation Method	Country	Condition
Selection of mental health health state utilities (Leijdesdorff SMJ et al., J Ment Health. 2023. doi:10.1080/09638237.2020.1836555)	2018 - 2019	EQ-5D-5L	Netherlands	Mental Health
DOI 10.7910/DVN/QNA5ZF Author(s) Registry, Utilities Description Health state utilities for mental health conditions Sample Characteristics 80 visitors of a Dutch multicenter organization for mental health support
Title Selection of autoimmune disease health state utilities (He A, Spelman T et al., J Neurol Neurosurg Psychiatry. 2023. doi:10.1136/jnnp-2022-330169)	Year(s) of data collection 2001 - 2020	Valuation Method EQ-5D-3L	Country Sweden	Condition Multiple sclerosis
DOI 10.7910/DVN/XTLOGB Author(s) Registry, Utilities Description Health state utilities for autoimmune disease conditions Sample Characteristics 690 adults with relapsing multiple sclerosis in a Swedish registry to examine the association between early treatment of multiple sclerosis and patient-reported outcomes
Title Selection of autoimmune disease health state utilities (Mitsikostas DD et al., Adv Ther. 2023. doi:10.1007/s12325-022-02388-8)	Year(s) of data collection 2012 - 2016	Valuation Method EQ-5D-3L	Country Greece	Condition Multiple sclerosis
DOI 10.7910/DVN/XTLOGB Author(s) Registry, Utilities Description Health state utilities for autoimmune disease conditions Sample Characteristics A prospective observational study of 458 participants under treatment with fingolimod conducted by hospital-based and private practice neurologists
Title Selection of orthopedic and musculoskeletal health state utilities (Kontodimopoulos N et al., J Clin Med. 2022. doi:10.3390/jcm11144097)	Year(s) of data collection 2020	Valuation Method EQ-5D-3L, EQ-5D-5L, SF-6D	Country Greece	Condition Ankylosing spondylities, Musculoskeletal disorders, Osteopenia/Osteporosis, Psoriaticc arthritis, Rheumatiod arthritis
DOI 10.7910/DVN/VR4XYO Author(s) Registry, Utilities Description Health state utilities for orthopedic and musculoskeletal conditions Sample Characteristics A cross-sectional sample of 315 (total) consecutive patients clinically diagnosed with RA, PsA, AS, or OsP/OP
Title Selection of autoimmune disease health state utilities (Saccà F et al., J Neurol. 2023. doi:10.1007/s00415-022-11517-w)	Year(s) of data collection 2018 - 2020	Valuation Method EQ-5D-5L	Country Belgium, Canada, Czechia, Denmark, France, Georgia, Germany, Hungary, Italy, Japan, Netherlands, Poland, Russian Federation, Serbia, United Kingdom of Great Britain and Northern Ireland, United States of America	Condition Myasthenia gravis
DOI 10.7910/DVN/XTLOGB Author(s) Registry, Utilities Description Health state utilities for autoimmune disease conditions Sample Characteristics 167 participants in phase 3 RCT of efgartigimod, ADAPT trial
Title Selection of autoimmune disease health state utilities (Dewilde S et al., Adv Ther. 2023. doi:10.1007/s12325-023-02437-w)	Year(s) of data collection 2021	Valuation Method EQ-5D-5L, HUI3	Country Belgium, Canada, Denmark, France, Germany, Italy, Japan, Netherlands, Spain, United Kingdom of Great Britain and Northern Ireland, United States of America	Condition Myasthenia gravis
DOI 10.7910/DVN/XTLOGB Author(s) Registry, Utilities Description Health state utilities for autoimmune disease conditions Sample Characteristics 9000 participants in the general population norms study that included adult patients with gMG randomly assigned to treatment with efgartigimod or conventional therapy
Title Selection of autoimmune disease health state utilities (Dewilde S et al., Adv Ther. 2023. doi:10.1007/s12325-023-02437-w)	Year(s) of data collection 2019 - 2022	Valuation Method EQ-5D-5L, HUI3	Country Canada, Denmark, France, Germany, Italy, Japan, Spain, United Kingdom of Great Britain and Northern Ireland, United States of America	Condition Myasthenia gravis
DOI 10.7910/DVN/XTLOGB Author(s) Registry, Utilities Description Health state utilities for autoimmune disease conditions Sample Characteristics 1299 participants (EQ-5D-5L) and 549 participants (HUI3) from MyRealWorld-MG study
Title Selection of orthopedic and musculoskeletal health state utilities (Zhou AK et al., Eur J Orthop Surg Traumatol. 2023. doi:10.1007/s00590-022-03204-3)	Year(s) of data collection 2014 - 2021	Valuation Method EQ-5D-5L	Country United Kingdom of Great Britain and Northern Ireland	Condition Open talus fractures
DOI 10.7910/DVN/VR4XYO Author(s) Registry, Utilities Description Health state utilities for orthopedic and musculoskeletal conditions Sample Characteristics 14 participants from the review of electronic hospital records, cohort
Title Selection of neurological disease health state utilities (Lacy B et al., Clin Park Relat Disord. 2023. doi:10.1016/j.prdoa.2022.100180)	Year(s) of data collection 2010 - 2011	Valuation Method EQ-5D	Country United States of America	Condition Parkinson's disease
DOI 10.7910/DVN/VJSSSX Author(s) Registry, Utilities Description Health state utilities for neurological disease conditions Sample Characteristics A cross-sectional study of 124 patients with PD at an academic movement clinic
Title Selection of neurological disease health state utilities (Looby A et al., J Med Econ. 2023. doi:10.1080/13696998.2023.2189395)	Year(s) of data collection 2022	Valuation Method EQ-5D-5L	Country United Kingdom of Great Britain and Northern Ireland	Condition Spinal cord injury
DOI 10.7910/DVN/VJSSSX Author(s) Registry, Utilities Description Health state utilities for neurological disease conditions Sample Characteristics A cohort of 57 patients with spinal cord injury

← Previous results Next results →